Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2012

01.10.2012 | Breast Oncology

Outcomes after Total Skin-sparing Mastectomy and Immediate Reconstruction in 657 Breasts

verfasst von: Anne Warren Peled, MD, Robert D. Foster, MD, Allison C. Stover, MPH, Kaoru Itakura, BA, Cheryl A. Ewing, MD, Michael Alvarado, MD, E. Shelley Hwang, MD, MPH, Laura J. Esserman, MD, MBA

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Total skin-sparing mastectomy (TSSM), a technique comprising removal of all breast and nipple tissue while preserving the entire skin envelope, is increasingly offered to women for therapeutic and prophylactic indications. However, standard use of the procedure remains controversial as a result oft concerns regarding oncologic safety and risk of complications.

Methods

Outcomes from a prospectively maintained database of patients undergoing TSSM and immediate breast reconstruction from 2001 to 2010 were reviewed. Outcome measures included postoperative complications, tumor involvement of the nipple–areolar complex (NAC) on pathologic analysis, and cancer recurrence.

Results

TSSM was performed on 657 breasts in 428 patients. Indications included in situ cancer [111 breasts (16.9 %)], invasive cancer [301 breasts (45.8 %)], and prophylactic risk-reduction [245 breasts (37.3 %)]. A total of 210 patients (49 %) had neoadjuvant chemotherapy, 78 (18.2 %) had adjuvant chemotherapy, and 114 (26.7 %) had postmastectomy radiotherapy. Nipple tissue contained in situ cancer in 11 breasts (1.7 %) and invasive cancer in 9 breasts (1.4 %); management included repeat excision (7 cases), NAC removal (9 cases), or radiotherapy without further excision (4 cases). Ischemic complications included 13 cases (2 %) of partial nipple loss, 10 cases (1.5 %) of complete nipple loss, and 78 cases (11.9 %) of skin flap necrosis. Overall locoregional recurrence rate was 2 % (median follow-up 28 months), with a 2.4 % rate observed in the subset of patients with at least 3 years’ follow-up (median 45 months). No NAC skin recurrences were observed.

Conclusions

In this large, high-risk cohort, TSSM was associated with low rates of NAC complications, nipple involvement, and locoregional recurrence.
Literatur
1.
Zurück zum Zitat de Alcantara Filho P, Capko D, Barry JM, Morrow M, Pusic A, Sacchini VS. Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. Ann Surg Oncol. 2011;18:3117–22.PubMedCrossRef de Alcantara Filho P, Capko D, Barry JM, Morrow M, Pusic A, Sacchini VS. Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. Ann Surg Oncol. 2011;18:3117–22.PubMedCrossRef
2.
Zurück zum Zitat Jensen JA, Orringer JS, Giuliano AE. Nipple-sparing mastectomy in 99 patients with a mean follow-up of 5 years. Ann Surg Oncol. 2011;18:1665–70.PubMedCrossRef Jensen JA, Orringer JS, Giuliano AE. Nipple-sparing mastectomy in 99 patients with a mean follow-up of 5 years. Ann Surg Oncol. 2011;18:1665–70.PubMedCrossRef
3.
Zurück zum Zitat Spear SL, Willey SC, Feldman ED, et al. Nipple-sparing mastectomy for prophylactic and therapeutic indications. Plast Reconstr Surg. 2011;128:1005–14.PubMedCrossRef Spear SL, Willey SC, Feldman ED, et al. Nipple-sparing mastectomy for prophylactic and therapeutic indications. Plast Reconstr Surg. 2011;128:1005–14.PubMedCrossRef
4.
Zurück zum Zitat Sacchini V, Pinotti JA, Barros AC, et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006;203:704–14.PubMedCrossRef Sacchini V, Pinotti JA, Barros AC, et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006;203:704–14.PubMedCrossRef
5.
Zurück zum Zitat Komorowski AL, Zanini V, Regolo L, Carolei A, Wysocki WM, Costa A. Necrotic complications after nipple- and areola-sparing mastectomy. World J Surg. 2006;30:1410–3.PubMedCrossRef Komorowski AL, Zanini V, Regolo L, Carolei A, Wysocki WM, Costa A. Necrotic complications after nipple- and areola-sparing mastectomy. World J Surg. 2006;30:1410–3.PubMedCrossRef
6.
Zurück zum Zitat Margulies AG, Hochberg J, Kepple J, Henry-Tillman RS, Westbrook K, Klimber VS. Total skin-sparing mastectomy without preservation of the nipple–areola complex. Am J Surg. 2005;190:907–12.PubMedCrossRef Margulies AG, Hochberg J, Kepple J, Henry-Tillman RS, Westbrook K, Klimber VS. Total skin-sparing mastectomy without preservation of the nipple–areola complex. Am J Surg. 2005;190:907–12.PubMedCrossRef
7.
Zurück zum Zitat Wijayanayagam A, Kumar AS, Foster RD, Esserman LJ. Optimizing the total skin-sparing mastectomy. Arch Surg. 2008;143:38–45.PubMedCrossRef Wijayanayagam A, Kumar AS, Foster RD, Esserman LJ. Optimizing the total skin-sparing mastectomy. Arch Surg. 2008;143:38–45.PubMedCrossRef
8.
Zurück zum Zitat Garwood ER, Moore D, Ewing C, et al. Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg. 2009;249:26–32.PubMedCrossRef Garwood ER, Moore D, Ewing C, et al. Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg. 2009;249:26–32.PubMedCrossRef
9.
Zurück zum Zitat Boneti C, Yuen J, Santiago C, et al. Oncologic safety of nipple skin-sparing or total skin-sparing mastectomies with immediate reconstruction. J Am Coll Surg. 2011;212:686–93.PubMedCrossRef Boneti C, Yuen J, Santiago C, et al. Oncologic safety of nipple skin-sparing or total skin-sparing mastectomies with immediate reconstruction. J Am Coll Surg. 2011;212:686–93.PubMedCrossRef
10.
Zurück zum Zitat Southern DA, Faris PD, Brant R, et al. Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol. 2006;59:1110–4.PubMedCrossRef Southern DA, Faris PD, Brant R, et al. Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol. 2006;59:1110–4.PubMedCrossRef
11.
Zurück zum Zitat Paepke S, Schmid R, Fleckner S, et al. Subcutaneous mastectomy with conservation of the nipple–areolar skin. Ann Surg. 2009;250:288–92.PubMedCrossRef Paepke S, Schmid R, Fleckner S, et al. Subcutaneous mastectomy with conservation of the nipple–areolar skin. Ann Surg. 2009;250:288–92.PubMedCrossRef
12.
Zurück zum Zitat Kim HJ, Park EH, Lim WS, et al. Nipple–areola skin-sparing mastectomy with immediate transverse rectus abdominis musculocutaneous flap reconstruction is an oncologically safe procedure: a single center study. Ann Surg. 2010;251:493–8.PubMedCrossRef Kim HJ, Park EH, Lim WS, et al. Nipple–areola skin-sparing mastectomy with immediate transverse rectus abdominis musculocutaneous flap reconstruction is an oncologically safe procedure: a single center study. Ann Surg. 2010;251:493–8.PubMedCrossRef
13.
Zurück zum Zitat Vaughn CJ, Warren Peled A, Esserman LJ, Foster RD. Feasbility of performing total skin-sparing mastectomy in patients with previous periareolar incisions. Presented at: California Society of Plastic Surgeons Annual Meeting, Coronado, CA, 2012. Vaughn CJ, Warren Peled A, Esserman LJ, Foster RD. Feasbility of performing total skin-sparing mastectomy in patients with previous periareolar incisions. Presented at: California Society of Plastic Surgeons Annual Meeting, Coronado, CA, 2012.
14.
Zurück zum Zitat Warren Peled A, Foster RD, Esserman LJ. A comparison of oncoplastic reduction mammoplasty and mastectomy with immediate reconstruction in patients with locally advanced breast cancer. Presented at: Pacific Coast Surgical Association Annual Meeting, Napa, CA, 2012. Warren Peled A, Foster RD, Esserman LJ. A comparison of oncoplastic reduction mammoplasty and mastectomy with immediate reconstruction in patients with locally advanced breast cancer. Presented at: Pacific Coast Surgical Association Annual Meeting, Napa, CA, 2012.
15.
Zurück zum Zitat Rusby JE, Gui GPH. Nipple-sparing mastectomy in women with large or ptotic breasts. J Plast Reconst Aesth Surg. 2010;63:e754–5.CrossRef Rusby JE, Gui GPH. Nipple-sparing mastectomy in women with large or ptotic breasts. J Plast Reconst Aesth Surg. 2010;63:e754–5.CrossRef
16.
Zurück zum Zitat Radovanovic Z, Radovanovic D, Golubovic A, Ivkovic-Kapicl T, Bokorov B, Mandic A. Early complications after nipple-sparing mastectomy and immediate breast reconstruction with silicone prosthesis: results of 214 procedures. Scand J Surg. 2010;99:115–8.PubMed Radovanovic Z, Radovanovic D, Golubovic A, Ivkovic-Kapicl T, Bokorov B, Mandic A. Early complications after nipple-sparing mastectomy and immediate breast reconstruction with silicone prosthesis: results of 214 procedures. Scand J Surg. 2010;99:115–8.PubMed
17.
Zurück zum Zitat Forbes JF, Cuzick J, Buzdar A, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008;9:45–53.PubMedCrossRef Forbes JF, Cuzick J, Buzdar A, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008;9:45–53.PubMedCrossRef
18.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of randomised trials. Lancet. 2005;365:1687–17. Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of randomised trials. Lancet. 2005;365:1687–17.
19.
Zurück zum Zitat Crowe JP, Patrick RJ, Yetman RJ, Djohan R. Nipple-sparing mastectomy update: one hundred forty-nine procedures and clinical outcomes. Arch Surg. 2008;143:1106–10.PubMedCrossRef Crowe JP, Patrick RJ, Yetman RJ, Djohan R. Nipple-sparing mastectomy update: one hundred forty-nine procedures and clinical outcomes. Arch Surg. 2008;143:1106–10.PubMedCrossRef
20.
Zurück zum Zitat Rusby JE, Brachtel EF, Michaelson JS, et al. Breast duct anatomy in the human nipple: three-dimensional patterns and clinical implications. Breast Cancer Res Treat. 2007;106:171–9.PubMedCrossRef Rusby JE, Brachtel EF, Michaelson JS, et al. Breast duct anatomy in the human nipple: three-dimensional patterns and clinical implications. Breast Cancer Res Treat. 2007;106:171–9.PubMedCrossRef
21.
Zurück zum Zitat Warren Peled A, Foster RD, Garwood ER, et al. The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study. Plast Reconstr Surg. In press. Warren Peled A, Foster RD, Garwood ER, et al. The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study. Plast Reconstr Surg. In press.
Metadaten
Titel
Outcomes after Total Skin-sparing Mastectomy and Immediate Reconstruction in 657 Breasts
verfasst von
Anne Warren Peled, MD
Robert D. Foster, MD
Allison C. Stover, MPH
Kaoru Itakura, BA
Cheryl A. Ewing, MD
Michael Alvarado, MD
E. Shelley Hwang, MD, MPH
Laura J. Esserman, MD, MBA
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2012
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2362-y

Weitere Artikel der Ausgabe 11/2012

Annals of Surgical Oncology 11/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.